Skip to content
Delayed ~15 min

PVLA PALVELLA THERAPEUTICS INC

Permanent stock page ↗

Health Care · Russell 2000

Next earnings: not announced yet

What 15 analyst firms say about PALVELLA THERAPEUTICS INC: their latest ratings, price targets and how far the stock is from them. How it works

175.92 USD+19.07 (+12.16%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 6 months

Analyst view · last 6M

+29.3%to the avg target 227.55 USD+51.63 USD
Buy 11 · Hold 1 · Sell 0

12 rated views · 15 analyst/firm records · 15 firms

Latest report28 Oct 2026avg report date 14 Jul
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MGood · #80 in the index82
  • Russell 2000 · Safest consensus · 6MGood · #27 in the index83

Recent analyst activity · last 90 days

Our tracked history has 9 reports on PVLA from 6 analyst firms in the last 90 days (22 firms in the past year).

Comparing each firm's latest target with its previous one: 1 lowered it and 2 left it unchanged.

No firm's latest available rating differs from its previous one.

Latest observed target change: HC Wainwright lowered its target from $270.00 (set 24 Mar 2026) to $246.00 on 12 Oct 2026.

Last 6 months. Latest opinion per identifiable analyst within the last 6 months. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
Canaccord GenuityWhitney IjemBuy18 May 2026232.00 USD
Cantor FitzgeraldJosh SchimmerBuy15 Jun 2026210.00 USD
Chardan Capital MarketsGautam ChukkaBuy28 Oct 2026240.00 USD
Craig-HallumAlbert LoweBuy22 Jun 2026205.00 USD
H.C. WainwrightAndrew S. FeinBuy20 Oct 2026246.00 USD · 12 Oct 2026
JonestradingCatherine NovackBuy7 May 2026209.00 USD
Lucid Capital MarketsDev PrasadBuy21 May 2026241.00 USD
MizuhoGraig SuvannavejhBuy10 Sep 2026Conflicting reports · excluded
Raymond JamesRyan Deschner—16 Oct 2026226.00 USD
StephensSudan LoganathanBuy21 May 2026220.00 USD
TD CowenRitu S BaralBuy15 Jun 2026267.00 USD
TruistDanielle BrillConflictConflicting reports · excluded5 Aug 2026207.00 USD
Weiss RatingsUnnamed analyst—25 Sep 2026—
William BlairAlethia YoungBuy16 Oct 2026—
Data feed RESEARCHResearch TeamHold15 Jun 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 02:55 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.